WO1997005879A1 - Reductions using hydrides - Google Patents
Reductions using hydrides Download PDFInfo
- Publication number
- WO1997005879A1 WO1997005879A1 PCT/US1996/002614 US9602614W WO9705879A1 WO 1997005879 A1 WO1997005879 A1 WO 1997005879A1 US 9602614 W US9602614 W US 9602614W WO 9705879 A1 WO9705879 A1 WO 9705879A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydride
- contacting
- lithium
- reduced
- aluminum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/023—Preparation; Separation; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Definitions
- This process concerns the use of certain alkali aluminum hydrides in the reduction of organic functional groups.
- reducing agents available for organic synthesis.
- sodium borohydride, borane, lithium aluminum hydride and hydrogen are all employed to perform reductions industrially.
- Lithium aluminum hydride (LiAIH 4 ) is a powerful reducing agent, soluble in organic solvents.
- This reagent has found wide utility in organic synthesis, due to its reducing power.
- a wide variety of functional groups are reduced with this reagent, including aldehydes, ketones, esters, amides, epoxides, nitriles and imides.
- the expense of lithium aluminum hydride prevents its wider industrial employment.
- the present invention describes less expensive alternatives for organic functional group reductions, using in situ generated alkali hydride reducing agents.
- One method involves the metathesis of sodium aluminum hydride (NaAIH ) with lithium chloride to form lithium aluminum hydride and sodium chloride (equation 1).
- Another method is the hydrogenation of a mixture of lithium (or lithium hydride) and aluminum to generate lithium aluminum hydride (equations 2 and 3).
- equations 1-3 There are several others variations of equations 1-3 as well as from aluminum chloride and alkali salts and hydrides (equations 4 and 5). It should be noted that preparations of lithium aluminum hydride are never targeted for the preparation of a mixed alkali aluminum hydride such as a mixture of lithium and sodium aluminum hydrides.
- the present invention overcomes these difficulties. It has been discovered that unfiltered solutions of lithium aluminum hydride (equations 1 to 5) are capable of reduction.
- the yields with the in situ reduction protocol are essentially identical to the yields obtained when the reduction is performed with filtered lithium aluminum hydride solution. Further, all functional groups that are typically reduced with filtered lithium aluminum hydride are reduced with the unfiltered lithium aluminum hydride solutions.
- Work-up of the reduction reaction and isolation of the reduced product involves employment of the standard procedure used for commercial lithium aluminum hydride. The inorganic by-products are most often removed by filtration or become part of any aqueous phase that may be present.
- (+/-) trans 3-ethoxycarbonyl-4-(4 - fluorophenyl)-N-methyl-piperidine-2,6-dione or (+/-) trans 3- methoxycarbonyl-4-(4'-fluorophenyl)-N-methyl-piperidine-2,6-dione with unfiltered lithium aluminum hydride afforded (+/-) ?ra ⁇ s-4-(4'-fluorophenyl)- 3-hydroxymethyl-N-methylpiperidine in essentially the same yields and with similar impurity profiles as with commercial LiAIH 4 .
- reductions can be accomplished with sodium aluminum hydride when its activity is modified with va ⁇ ous additives.
- sodium aluminum hydride NaAIH
- NaAIH sodium aluminum hydride
- the additive lithium chloride
- sodium aluminum hydride could be mixed with sodium aluminum hydride in order to produce a resulting hydride that performed as well as sodium aluminum hydride with the additive, lithium aluminum hydride, or lithium aluminum hydride alone.
- LiCl can be reacted with NaAIH 4 in stoichiometric amounts to form lithium aluminum hydride (equation 1), which is then separated from the by-product, NaCl, prior to use.
- equation 1 lithium aluminum hydride
- NaCl sodium hydride
- LiCl can be added in less than stoichiometric amounts and the NaCl is not separated from the resulting hydride. This invention shows that this filtration is unnecessary.
- the additives can be added at various times during the entire reduction. Although NaAIH 4 without additives may be less reactive in some cases, it is superior due to the high cost of LiAIH 4 . Reductions of functional groups, especially imides, employing NaAIH 4 with the appropriate additives gave identical results as obtained when using the more costly, commercial LiAIH .
- (+/-) trans 3-ethoxycarbonyl-4-(4'- fluorophenyl)-N-methyl-piperidine-2,6-dione afforded (+/-) frans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine in essentially the same yield and with similar impurity profile as with commercial LiAIH 4 .
- inorganic or organic additives can be added to either reduction protocol to aid the reduction.
- These additives can be employed in 0.01 equivalents up to and including 5 equivalents.
- useful additives which can be used in combination as well, include, but are not limited to LiCl.
- Example 6 Reduction of ( ⁇ )-Tra ⁇ s-3-Ethoxycarbonyl-4-(4'-Fluorophenyl)-N- Methylpiperidin-2,6-Dione with NaAIH4/LiAIH 4
- NaAIH4/LiAIH 4 0.22 mol
- toluene/THF under argon is added (+/-) trans -3-ethoxycarbonyl-4-(4'- fluorophenyl)-N-methyl-piperidine-2,6-dione (0.083 mol) in THF holding the temperature below 15 °C. After addition is complete, the reaction is allowed to warm to room temperature.
- LiCl (0.11 mol) in THF.
- LiCl can be added to the reactor prior to the addition of NaAIH or after the addition of the substrate, (+/-) trans 3- ethoxycarbonyl- -(4'-fluorophenyl)-N-methyl-piperidine-2,6-dione.
- (+/-) trans 3-ethoxycarbonyl-4-(4'-fluorophenyl)-N-methyl-piperidine-2, 6- dione (0.083 mol) is added in THF (65 ml) holding the temperature below 15 °C. After addition is completed, reaction is allowed to warm to room temperature.
- LiCl (0.11 mol) in THF.
- LiCl can be added to the reactor prior to the addition of NaAIH 4 or after the addition of the substrate.
- N-methylsuccinimide (0.083 mol) in THF is added holding the temperature below 15 °C.
- the reaction is allowed to warm to room temperature. After 30 minutes at room temperature reaction is heated to > 40 °C for 2 hr. The reaction is then cooled to ⁇ 5 °C and toluene (50 ml) is added. Water (9 ml) is then added slowly holding the temperature below 15 °C.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Description
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96906645A EP0789573A4 (en) | 1995-08-03 | 1996-02-28 | Reductions using hydrides |
| AU49970/96A AU4997096A (en) | 1995-08-03 | 1996-02-28 | Reductions using hydrides |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US185795P | 1995-08-03 | 1995-08-03 | |
| US60/001,857 | 1995-08-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1997005879A1 true WO1997005879A1 (en) | 1997-02-20 |
Family
ID=21698146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1996/002614 Ceased WO1997005879A1 (en) | 1995-08-03 | 1996-02-28 | Reductions using hydrides |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0789573A4 (en) |
| AU (1) | AU4997096A (en) |
| WO (1) | WO1997005879A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998013319A1 (en) * | 1996-09-24 | 1998-04-02 | Fmc Corporation | Novel reduction compositions and processes for making the same |
| US6444190B2 (en) | 1995-08-03 | 2002-09-03 | Fmc Corporation | Reduction compositions and processes for making the same |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4902801A (en) * | 1985-08-10 | 1990-02-20 | Beecham Group Plc. | Process for preparing aryl-piperidine carbinols and novel intermediates used in the process |
| US5258517A (en) * | 1992-08-06 | 1993-11-02 | Sepracor, Inc. | Method of preparing optically pure precursors of paroxetine |
-
1996
- 1996-02-28 WO PCT/US1996/002614 patent/WO1997005879A1/en not_active Ceased
- 1996-02-28 AU AU49970/96A patent/AU4997096A/en not_active Abandoned
- 1996-02-28 EP EP96906645A patent/EP0789573A4/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4902801A (en) * | 1985-08-10 | 1990-02-20 | Beecham Group Plc. | Process for preparing aryl-piperidine carbinols and novel intermediates used in the process |
| US5258517A (en) * | 1992-08-06 | 1993-11-02 | Sepracor, Inc. | Method of preparing optically pure precursors of paroxetine |
Non-Patent Citations (5)
| Title |
|---|
| CASREACT on STN, Chemical Abstracts Service, (Columbus, OH), 115:91342, GYOUNG, Y.S. et al., "A Convenient Procedure for the Conversion of Tertiary Amides to the Corresponding Alcohols with Lithium Aluminum Hydride", Reaction (1) of 2; & J. KOREAN CHEM. SOC., 35(3), 1991. * |
| CASREACT on STN, Chemical Abstracts Service, (Columbus, OH), 120:8801, ABRAHAM, J. et al., "Steroids and Related Studies. Part 90. Certain New Azasteroidal Bisquaternary Neuromuscular Blockers", Reaction (2) of 16; & EUR. J. MED. CHEM., 28(3), 1993. * |
| CASREACT on STN, Chemical Abstracts Service, (Columbus, OH), 123:286279, ARITSUKA, M. et al., "Preparation of Alkenysilanes from Alkenychlorosilanes", Reaction (1) of 1; & JP,A,07 173 173 (MITSUI TOATSU CHEMICALS) 11 July 1995. * |
| J. MED. CHEM., 05 August 1994, Vol. 37, No. 16, MACOR, J.E. et al., "5-((3-Nitropyrid-2-yl)amino)indoles: Novel Serotonin Agonist with Selectivity for the 5-HT1D Receptor. Variation of the C3 Substituent on the Indole Template Leads to Increased 5-HT1D Receptor Selectivity", pages 2509-2512. * |
| See also references of EP0789573A4 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6444190B2 (en) | 1995-08-03 | 2002-09-03 | Fmc Corporation | Reduction compositions and processes for making the same |
| WO1998013319A1 (en) * | 1996-09-24 | 1998-04-02 | Fmc Corporation | Novel reduction compositions and processes for making the same |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0789573A1 (en) | 1997-08-20 |
| EP0789573A4 (en) | 1998-04-29 |
| AU4997096A (en) | 1997-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002518362A (en) | Catalytic titanium (IV) oxide-induced geminal symmetric dialkylation of carboxamides | |
| EP1463729B1 (en) | A process for producing phenserine and its analog | |
| KR960000758B1 (en) | Optically active hydroxybenzylamine derivatives and preparation method thereof | |
| EP0789573A1 (en) | Reductions using hydrides | |
| CA1306597C (en) | Process for preparing halogen magnesium alanate and use thereof | |
| CA2570833C (en) | Process for producing (z)-1-phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane hydrochloride | |
| US6444190B2 (en) | Reduction compositions and processes for making the same | |
| EP0983237B1 (en) | Chemical process for the reduction of 1-substituted -3-hydroxymethyl-4- (4-fluorophenyl)tetrahydropyridines | |
| JP3937275B2 (en) | Process for producing trifluoromethylbenzylamines | |
| US6060617A (en) | Contaminant free organometallic amide compositions and processes for making same | |
| JP2002518364A (en) | Symmetric and asymmetric disubstitution of carboxamides using organic titanates and Grignard reagents | |
| EP0126470B1 (en) | Process for the preparation of tamoxifen | |
| JP3282357B2 (en) | Piperonal manufacturing method | |
| JP3123815B2 (en) | Method for producing 2-chloro-5-chloromethylpyridine and / or 2-chloro-5-dichloromethylpyridine | |
| JPH11322643A (en) | Production of chloroalkyne and alkynylamine | |
| JP2992334B2 (en) | Process for producing 2,4,5-tribromopyrrole-3-carbonitrile compound as molluscicide | |
| KR970004595B1 (en) | Process for preparing 3-amino-1-benzylpyrrolidines | |
| US6515180B1 (en) | Method for the catalytic, symmetric disubstitution of carboxylic acid amides with grignard reagents | |
| US6448445B1 (en) | Method for catalytically disubstituting carboxylic acid amides with at least one grignard reagent | |
| JP2689590B2 (en) | Process for producing 4-methyl-4-hydroxy-1-octyne | |
| JPH0250101B2 (en) | ||
| JP3393882B2 (en) | Method for producing 4-amino-3-fluorobenzotrifluoride | |
| JPH0841065A (en) | Production of 1-azabicyclo(3.3.0)octane derivative | |
| JPH0637435B2 (en) | Method for producing N, N'-dialkylethylenediamine | |
| CN108329248B (en) | Preparation method of 2-methylindoline |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN |
|
| ENP | Entry into the national phase |
Ref country code: US Ref document number: 1997 817003 Date of ref document: 19970331 Kind code of ref document: A Format of ref document f/p: F |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1996906645 Country of ref document: EP |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWP | Wipo information: published in national office |
Ref document number: 1996906645 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1996906645 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: CA |